RuddP., BlaschkeT.F.Pharmacology of specific antihypertensive agents. In: Goodman and Gilman's—The Pharmacological Basis of Therapeutics.7th Edition.GilmanA.G., GoodmanL.S., RallT.W., MuradF. eds. New York, Macmillan1985; 784–805.
2.
DehringD.J., GuptaB., PeruzziW.T.Postoperative opisthotonus and torticollis after fentanyl, enflurane, and nitrous oxide.Can J Anaesth1991; 38(7): 919–925.
3.
WilletteR.N., DoorleyB.M., SapruH.N.Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression.J Pharmacol Exp Ther1987; 240(1): 352–8.
4.
WoodM.Cholinergic and Parasympathomimetic Drugs. Cholinesterases and anticholinesterases. In: Drugs and anesthesia—Pharmacology for Anesthesiologists.2nd Edition.WoodM., WoodA.J.J. eds. Williams and Walkins, Baltimore1990; 83–109.
5.
HerschmanZ.J., SilversteinJ., BlumbergG., LehrfieldA.Central nervous system toxicity from nebulized atropine sulfate.J Toxicol Clin Toxicol1991; 29(2): 273–7.
6.
HerschmanZ., KaufmanB.Complications arising from the use of ophthalmologic medications in an intensive care unit patient.NY State J Med1989; 89: 537–8.
7.
RumackB.H., LovejoyF.H.Clinical toxicology. In Cassrett and Doull's Toxicology—The Basic Science of Poisons.3rd Edition, KlaassenC.D., AmdurM.O., DoullJ. eds. New York, Macmillan1986; 879–901.
8.
LauvenP.M., StoeckelH.Flumazenil (Ro 15–1788) and physostigmine.Resuscitation1988; 16 Suppl: S41–8.
9.
SchneckH.J., RuprehtJ.Central anticholinergic syndrome in anesthesia and intensive care.Acta Anaesthesiol Belg1989; 40(3): 219–28.
ReprehtJ.The central muscarinic transmission during anaesthesia and recovery—the central anticholinergic syndrome.Anaesthesiol Reanim1991; 16(4): 250–8.
12.
GranacherR.P., BaldessarineR.J., MessnerE.Physostigmine treatment of delirium induced by anticholinergics.Am Fam Physician1976; 13: 99–103.
13.
CurtisD., StevensW.C.Recovery from general anesthesia.Int Anesthesiol Clin1991; 29(2): 1–11.